Literature DB >> 7677543

Myocardial protection in the immature heart.

J W Hammon1.   

Abstract

In an era when essentially no congenital heart defect is considered inoperable, it is reasonable to carefully consider the essentials of neonatal myocardial physiology and biochemistry, especially comparisons between immature and adult myocardial responses to ischemia. Because many special clinical interactions dramatically affect myocardial protection, great care must be taken to analyze each case carefully with protection strategies in mind. Finally, cardioplegia composition and delivery are now quite similar to those used in adults, with new equipment facilitating delivery. Research is underway to supplement protection in immature hearts severely injured by adverse preoperative conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677543     DOI: 10.1016/0003-4975(95)00573-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial.

Authors:  Massimo Caputo; Amir Mokhtari; Chris A Rogers; Nayia Panayiotou; Qiang Chen; Mohamed T Ghorbel; Gianni D Angelini; Andrew J Parry
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02-23       Impact factor: 5.209

2.  Retrograde hot-shot cardioplegia in patients with left ventricular hypertrophy undergoing aortic valve replacement.

Authors:  Raimondo Ascione; Saadeh M Suleiman; Gianni D Angelini
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

Review 3.  Dexmedetomidine: a review of applications for cardiac surgery during perioperative period.

Authors:  Xiaoyu Zhang; Xuan Zhao; Yingwei Wang
Journal:  J Anesth       Date:  2014-06-10       Impact factor: 2.078

4.  Influence of repeated bouts of table tennis training on cardiac biomarkers in children.

Authors:  Guodong Ma; Yanhuan Liu; Kemin Liu
Journal:  Pediatr Cardiol       Date:  2013-11-23       Impact factor: 1.655

5.  Normoxic and hyperoxic cardiopulmonary bypass in congenital heart disease.

Authors:  Amir Mokhtari; Martin Lewis
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

6.  Influence of percutaneous catheter intervention for congenital perimembranous ventricular septal defects in children on the cardiac conduction system and associated risk factors: a meta-analysis.

Authors:  Yu-Qing Lei; Wen-Hao Lin; Shi-Hao Lin; Wen-Peng Xie; Jian-Feng Liu; Qiang Chen; Hua Cao
Journal:  J Cardiothorac Surg       Date:  2022-02-16       Impact factor: 1.637

7.  Myocardial oxygen consumption during histidine-tryptophan-ketoglutarate cardioplegia in young human hearts.

Authors:  Emanuela Angeli; Sabrina Martens; Lucio Careddu; Francesco D Petridis; Andrea G Quarti; Cristina Ciuca; Anna Balducci; Assunta Fabozzo; Luca Ragni; Andrea Donti; Gaetano D Gargiulo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

8.  Transcatheter Device Closure of Perimembranous Ventricular Septal Defect in Pediatric Patients: Long-Term Outcomes.

Authors:  Jayal Hasmukhbhai Shah; Sanket Pravinchandra Saraiya; Tushar Sudhakarrao Nikam; Mukesh Jitendra Jha
Journal:  Heart Views       Date:  2020-01-23

9.  Intermittent antegrade warm-blood versus cold-blood cardioplegia in children undergoing open heart surgery: a protocol for a randomised controlled study (Thermic-3).

Authors:  Rachael Heys; Serban Stoica; Gianni Angelini; Richard Beringer; Rebecca Evans; Mohamed Ghorbel; William Lansdowne; Andrew Parry; Guido Pieles; Barnaby Reeves; Chris Rogers; Rohit Saxena; Karen Sheehan; Stella Smith; Terrie Walker-Smith; Robert Mr Tulloh; Massimo Caputo
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

10.  Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.

Authors:  F Berger; S Schubert; M Bergmann; C P Germann; J Nordmeyer; B Peters
Journal:  Pediatr Cardiol       Date:  2020-10-03       Impact factor: 1.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.